BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1725225)

  • 1. [The effect of combined therapy with the use of thymalin and piracetam on the level of middle-molecule peptides in the blood and on the lipid peroxidation activity in patients with diffuse toxic goiter].
    Iangolenko VV
    Ter Arkh; 1991; 63(10):60-3. PubMed ID: 1725225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes of the blood kallikrein-kinin system in patients with diffuse toxic goiter under the influence of thyrostatic therapy and prodectin].
    Matiashina GI
    Vrach Delo; 1989 Apr; (4):31-3. PubMed ID: 2474220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experience using lithium carbonate in the complex treatment of diffuse toxic goiter].
    Petrov NM
    Ter Arkh; 1985; 57(12):32-6. PubMed ID: 3937256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood levels of medium molecular weight peptides and lipid peroxidation activity in the differential diagnosis of diffuse toxic goiter].
    Iangolenko VV; Okorokov AN
    Probl Endokrinol (Mosk); 1991; 37(1):10-2. PubMed ID: 2027858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thymalin in the combined treatment of patients with chronic lympholeukemia].
    Babenko TF; Antonenko VT; SkuratovskiUi MF
    Vrach Delo; 1989 Mar; (3):47-9. PubMed ID: 2750120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunological and metabolic disorders and the means for their correction in patients with chronic bronchitis].
    Sil'vestrov VP; Kinitin AV; Chesnokova IV
    Ter Arkh; 1991; 63(12):7-11. PubMed ID: 1803607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of thymalin and heparin in acute peritonitis].
    Kokotov IuK; Budazhabon GB; Kuznik BI; Darenskiĭ DI; Morozov VG
    Vestn Khir Im I I Grek; 1986 Feb; 136(2):53-6. PubMed ID: 3754668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of taktivin and levamisole in the combined treatment of diffuse toxic goiter].
    Balabolkin MI; Arion VIa; Petunina NA
    Sov Med; 1987; (12):32-5. PubMed ID: 3502197
    [No Abstract]   [Full Text] [Related]  

  • 9. [Correlation between the protein-bound iodine and butanol-extracted iodine in the blood serum of patients with diffuse toxic goiter during treatment with mercazolyl].
    Okulov VB
    Probl Endokrinol (Mosk); 1969; 15(4):5-8. PubMed ID: 4189655
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of thymalin in the combined chemotherapy of patients with infiltrative destructive pulmonary tuberculosis].
    Ivanova LA
    Vrach Delo; 1989 Oct; (10):57-9. PubMed ID: 2617987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of a levopromazine-thymalin combination on the development of toxic edema and swelling in the brain].
    Platonov IA; Vonogel' VG; Andreeva TA
    Eksp Klin Farmakol; 2004; 67(1):48-50. PubMed ID: 15079910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [T-cell immunity and immunomodulators in the comprehensive treatment of diffuse toxic goiter].
    Petunina NA; Balabolkin MI; Arion VIa
    Ross Med Zh; 1992; (5-12):19-24. PubMed ID: 1286263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of thymalin in the combined treatment of patients with disseminated cancer of the cervix uteri].
    Vishnevskaia EE; Khavinson VKh; Nikolaeva DV
    Vopr Onkol; 1991; 37(1):86-90. PubMed ID: 2014686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical efficacy of treating patients with acute pneumonias by using drug and quantum correction of the lipid peroxidation-antioxidant system].
    Provotorov VM; Zizemskaia EV
    Ter Arkh; 1992; 64(3):29-32. PubMed ID: 1440270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term evolution of immunologic and thyroid function in Graves disease according different therapeutic options].
    Campos Pastor MM; Fernández Soto ML; Escobar-Jiménez F; Barredo Acedo F; Ruiz de Almodóvar M
    Med Clin (Barc); 1994 Apr; 102(12):446-50. PubMed ID: 7516033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients.
    Yavuz DG; Yüksel M; Deyneli O; Ozen Y; Aydin H; Akalin S
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):515-21. PubMed ID: 15473886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Amino acid composition of the blood in patients with diffuse toxic goiter during conservative therapy].
    Borodina LV
    Ter Arkh; 1987; 59(6):100-3. PubMed ID: 3629484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
    Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
    Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunogenesis and hemostasis in patients with exacerbated chronic glomerulonephritis treated with thymalin].
    Budazhabon GV; Kuznik BI; Morozov VG; Orlova NN; Khavinson VKh
    Ter Arkh; 1984; 56(10):62-6. PubMed ID: 6549229
    [No Abstract]   [Full Text] [Related]  

  • 20. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
    Berg GE; Michanek AM; Holmberg EC; Fink M
    J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.